NCT03707795View on ClinicalTrials.gov

Treatment of FUS-Related ALS With Betamethasone - The TRANSLATE Study

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 21, 2017

Primary Completion Date

January 10, 2019

Study Completion Date

January 10, 2019

Conditions
Familial Amyotrophic Lateral Sclerosis
Interventions
DRUG

Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days

Participants will be given four IM injections throughout the study

Trial Locations (1)

40475

University of Kentucky Medical Center, Lexington

All Listed Sponsors
lead

Edward Kasaraskis

OTHER

NCT03707795 - Treatment of FUS-Related ALS With Betamethasone - The TRANSLATE Study | Biotech Hunter | Biotech Hunter